Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy
Phase 2
Recruiting
- Conditions
- Gestational Trophoblastic Neoplasia
- Interventions
- Drug: PD-1 inhibitor， bevacizumab
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2022-06-03
- Target Recruit Count
- 20
- Registration Number
- NCT04812002
- Locations
- 🇨🇳
Women's Hospital School of Medicine Zhejiang University, Hangzhou, Zhejiang, China
D-chiro Inositol in Prevention of Gestational Diabetes Mellitus in China
Not Applicable
Completed
- Conditions
- Gestational Diabetes Mellitus in Pregnancy
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: D-chiro inositol
- First Posted Date
- 2021-03-17
- Last Posted Date
- 2025-04-17
- Target Recruit Count
- 291
- Registration Number
- NCT04801485
- Locations
- 🇨🇳
Xinning Chen, Hangzhou, Zhejiang, China
Self-controlled Study Between 4-hour and 24-hour Delayed Radiographs in HSG Using OSCM
Not Applicable
- Conditions
- Infertility
- Interventions
- Diagnostic Test: Add 4-hour delayed radiographs
- First Posted Date
- 2021-02-09
- Last Posted Date
- 2021-02-09
- Target Recruit Count
- 80
- Registration Number
- NCT04744610
- Locations
- 🇨🇳
Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
Gestational Weight Gain Criteria for Pregnant Women With Gestational Diabetes Mellitus in China
Recruiting
- Conditions
- Gestational Weight Gain
- First Posted Date
- 2021-02-09
- Last Posted Date
- 2023-02-21
- Target Recruit Count
- 10000
- Registration Number
- NCT04744714
- Locations
- 🇨🇳
Women's Hospital School of Medicine Zhejiang University, Hangzhou, China
A Multicenter Study of the Efficacy and Safety of Esketamine for Analgesia During Cesarean Section
Phase 4
Completed
- Conditions
- Fetal or Neonatal Effect of Damage to Placenta From Caesarean Section
- Interventions
- Drug: Normal saline
- First Posted Date
- 2020-09-16
- Last Posted Date
- 2024-12-04
- Target Recruit Count
- 600
- Registration Number
- NCT04548973
- Locations
- 🇨🇳
Women's Hospital School of Medicine Zhejiang University, Hangzhou, Zhejiang, China
Natural Cycle or Stimulated Cycle Versus Hormone Replaced Cycle for Pre-eclampsia Rate
Not Applicable
- Conditions
- Pre-Eclampsia
- Interventions
- Other: natural cycle for endometrium preparationOther: hormone replaced cycle for endometrium preparation
- First Posted Date
- 2020-03-17
- Last Posted Date
- 2020-03-17
- Target Recruit Count
- 840
- Registration Number
- NCT04310683
Vitamin D and Pregnancy Outcome in PCOS Patients
Not Applicable
Completed
- Conditions
- in Vitro FertilizationPolycystic Ovary Syndrome
- Interventions
- Other: Placebo
- First Posted Date
- 2019-09-09
- Last Posted Date
- 2025-01-29
- Target Recruit Count
- 876
- Registration Number
- NCT04082650
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
🇨🇳Women's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Epigenetic Safety of Assisted Reproductive Technology
Not yet recruiting
- Conditions
- Infertility
- Interventions
- Other: Completion questionnaires/providing biological samples
- First Posted Date
- 2019-08-22
- Last Posted Date
- 2019-08-22
- Target Recruit Count
- 15000
- Registration Number
- NCT04065945
- Locations
- 🇨🇳
Women's Hospital School of Medicine Zhejiang University, Hangzhou, Zhejiang, China
Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6
Phase 2
- Conditions
- Drug ToxicityGestational Trophoblastic TumorEffects of Chemotherapy
- Interventions
- Drug: MTX+ACTD
- First Posted Date
- 2019-03-21
- Last Posted Date
- 2019-03-21
- Target Recruit Count
- 300
- Registration Number
- NCT03885388
- Locations
- 🇨🇳
Weiguo Lv, Hangzhou, Zhejiang, China
Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer
Phase 4
- Conditions
- Efficacy and Safety
- Interventions
- First Posted Date
- 2019-01-07
- Last Posted Date
- 2022-07-18
- Target Recruit Count
- 396
- Registration Number
- NCT03794778
- Locations
- 🇨🇳
Women's Hospital School Of Medicine Zhejiang University, Zhejiang, Hangzhou, China
© Copyright 2025. All Rights Reserved by MedPath